Ethylaminopyrazine Rifaximin Tablets ll belongs to the anti-tuberculosis group of drugs and is a complex formulation containing four first-line anti-tuberculosis drugs. It is commonly used in the treatment of tuberculosis in adults. Ethylaminopyrazine Rifaximin Tablet ll is mainly used for the first 2 months of intensive treatment in a short course of tuberculosis therapy, after which rifampicin and isoniazid are still needed to continue treatment for at least 4 months. It is effective in skin tuberculosis and lymphatic tuberculosis. Prolonged use can cause eye discomfort, back pain, headache, nausea and other symptoms. Allergic people are prohibited from taking it. It should be taken correctly according to the doctor’s instructions, and it is forbidden to mix and match medicines, increase or decrease the dosage of medicines arbitrarily, and so on.